ID   LDHA_HUMAN              Reviewed;         332 AA.
AC   P00338; B4DKQ2; B7Z5E3; D3DQY3; F8W819; Q53G53; Q6IBM7; Q6ZNV1; Q9UDE8;
AC   Q9UDE9;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   28-JUN-2023, entry version 255.
DE   RecName: Full=L-lactate dehydrogenase A chain {ECO:0000305};
DE            Short=LDH-A;
DE            EC=1.1.1.27 {ECO:0000269|PubMed:11276087};
DE   AltName: Full=Cell proliferation-inducing gene 19 protein;
DE   AltName: Full=LDH muscle subunit;
DE            Short=LDH-M {ECO:0000303|PubMed:11276087};
DE   AltName: Full=Renal carcinoma antigen NY-REN-59;
GN   Name=LDHA {ECO:0000312|HGNC:HGNC:6535}; ORFNames=PIG19;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3838278; DOI=10.1111/j.1432-1033.1985.tb08711.x;
RA   Tsujibo H., Tiano H.F., Li S.S.-L.;
RT   "Nucleotide sequences of the cDNA and an intronless pseudogene for human
RT   lactate dehydrogenase-A isozyme.";
RL   Eur. J. Biochem. 147:9-15(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RX   PubMed=3000353; DOI=10.1042/bj2310537;
RA   Chung F.Z., Tsujibo H., Bhattacharyya U., Sharief F.S., Li S.S.-L.;
RT   "Genomic organization of human lactate dehydrogenase-A gene.";
RL   Biochem. J. 231:537-541(1985).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kim J.W.;
RT   "Identification of a human proliferation-inducing gene.";
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 3 AND 4).
RC   TISSUE=Umbilical cord;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT GLU-222.
RC   TISSUE=Gastric carcinoma;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-14; 43-57; 60-73; 77-112; 133-149; 158-169; 233-243;
RP   306-315 AND 319-328, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT
RP   ALA-2, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (MAR-2005) to UniProtKB.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 112-121 AND 160-175.
RX   PubMed=1953713; DOI=10.1016/s0006-291x(05)81177-5;
RA   Maekawa M., Sudo K., Li S.S., Kanno T.;
RT   "Analysis of genetic mutations in human lactate dehydrogenase-A(M)
RT   deficiency using DNA conformation polymorphism in combination with
RT   polyacrylamide gradient gel and silver staining.";
RL   Biochem. Biophys. Res. Commun. 180:1083-1090(1991).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 250-254.
RX   PubMed=1959923; DOI=10.1007/bf00204925;
RA   Maekawa M., Sudo K., Li S.S., Kanno T.;
RT   "Genotypic analysis of families with lactate dehydrogenase A (M) deficiency
RT   by selective DNA amplification.";
RL   Hum. Genet. 88:34-38(1991).
RN   [13]
RP   INVOLVEMENT IN GSD11.
RX   PubMed=2334430; DOI=10.1016/0006-291x(90)92374-9;
RA   Maekawa M., Sudo K., Kanno T., Li S.S.;
RT   "Molecular characterization of genetic mutation in human lactate
RT   dehydrogenase-A (M) deficiency.";
RL   Biochem. Biophys. Res. Commun. 168:677-682(1990).
RN   [14]
RP   IDENTIFICATION AS A RENAL CANCER ANTIGEN.
RC   TISSUE=Renal cell carcinoma;
RX   PubMed=10508479;
RX   DOI=10.1002/(sici)1097-0215(19991112)83:4<456::aid-ijc4>3.0.co;2-5;
RA   Scanlan M.J., Gordan J.D., Williamson B., Stockert E., Bander N.H.,
RA   Jongeneel C.V., Gure A.O., Jaeger D., Jaeger E., Knuth A., Chen Y.-T.,
RA   Old L.J.;
RT   "Antigens recognized by autologous antibody in patients with renal-cell
RT   carcinoma.";
RL   Int. J. Cancer 83:456-464(1999).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [16]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [18]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-10, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-5; LYS-14; LYS-57; LYS-81;
RP   LYS-118; LYS-126 AND LYS-318, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22905912; DOI=10.1021/pr300539b;
RA   Rosenow A., Noben J.P., Jocken J., Kallendrusch S., Fischer-Posovszky P.,
RA   Mariman E.C., Renes J.;
RT   "Resveratrol-induced changes of the human adipocyte secretion profile.";
RL   J. Proteome Res. 11:4733-4743(2012).
RN   [23]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-18 AND SER-310, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-310, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [27]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-57, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [28]
RP   INTERACTION WITH MP31, AND MUTAGENESIS OF ASP-56 AND ARG-99.
RX   PubMed=33406399; DOI=10.1016/j.cmet.2020.12.008;
RA   Huang N., Li F., Zhang M., Zhou H., Chen Z., Ma X., Yang L., Wu X.,
RA   Zhong J., Xiao F., Yang X., Zhao K., Li X., Xia X., Liu Z., Gao S.,
RA   Zhang N.;
RT   "An Upstream Open Reading Frame in Phosphatase and Tensin Homolog Encodes a
RT   Circuit Breaker of Lactate Metabolism.";
RL   Cell Metab. 33:128-144(2021).
RN   [29]
RP   ERRATUM OF PUBMED:33406399.
RX   PubMed=33535099; DOI=10.1016/j.cmet.2021.01.008;
RA   Huang N., Li F., Zhang M., Zhou H., Chen Z., Ma X., Yang L., Wu X.,
RA   Zhong J., Xiao F., Yang X., Zhao K., Li X., Xia X., Liu Z., Gao S.,
RA   Zhang N.;
RL   Cell Metab. 33:454-454(2021).
RN   [30]
RP   ACTIVITY REGULATION, INTERACTION WITH FLCN, AND MUTAGENESIS OF ARG-106.
RX   PubMed=34381247; DOI=10.1038/s41594-021-00633-2;
RA   Woodford M.R., Baker-Williams A.J., Sager R.A., Backe S.J., Blanden A.R.,
RA   Hashmi F., Kancherla P., Gori A., Loiselle D.R., Castelli M.,
RA   Serapian S.A., Colombo G., Haystead T.A., Jensen S.M.,
RA   Stetler-Stevenson W.G., Loh S.N., Schmidt L.S., Linehan W.M., Bah A.,
RA   Bourboulia D., Bratslavsky G., Mollapour M.;
RT   "The tumor suppressor folliculin inhibits lactate dehydrogenase A and
RT   regulates the Warburg effect.";
RL   Nat. Struct. Mol. Biol. 28:662-670(2021).
RN   [31]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEX WITH NADH AND SUBSTRATE
RP   ANALOG, HOMOTETRAMERIZATION, CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=11276087;
RX   DOI=10.1002/1097-0134(20010501)43:2<175::aid-prot1029>3.0.co;2-#;
RA   Read J.A., Winter V.J., Eszes C.M., Sessions R.B., Brady R.L.;
RT   "Structural basis for altered activity of M- and H-isozyme forms of human
RT   lactate dehydrogenase.";
RL   Proteins 43:175-185(2001).
RN   [32]
RP   VARIANT CYS-315.
RX   PubMed=1445373;
RA   Sudo K., Maekawa M., Shioya M., Ikeda K., Takahashi N., Isogai Y.,
RA   Li S.S.-L., Kanno T., Machida K., Toriumi J.;
RT   "Molecular analysis of genetic mutation in electrophoretic variant of human
RT   lactate dehydrogenase-A(M) subunit.";
RL   Biochem. Int. 27:1051-1057(1992).
RN   [33]
RP   VARIANT GLU-222.
RX   PubMed=7908613;
RA   Maekawa M., Sudo K., Kobayashi A., Sugiyama E., Li S.S.-L., Kanno T.;
RT   "Fast-type electrophoretic variant of lactate dehydrogenase M(A) and
RT   comparison with other missense mutations in lactate dehydrogenase M(A) and
RT   H(B) genes.";
RL   Clin. Chem. 40:665-668(1994).
CC   -!- FUNCTION: Interconverts simultaneously and stereospecifically pyruvate
CC       and lactate with concomitant interconversion of NADH and NAD(+).
CC       {ECO:0000269|PubMed:11276087}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(S)-lactate + NAD(+) = H(+) + NADH + pyruvate;
CC         Xref=Rhea:RHEA:23444, ChEBI:CHEBI:15361, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:16651, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.1.1.27;
CC         Evidence={ECO:0000269|PubMed:11276087};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:23445;
CC         Evidence={ECO:0000269|PubMed:11276087};
CC       PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:23446;
CC         Evidence={ECO:0000269|PubMed:11276087};
CC   -!- ACTIVITY REGULATION: Fermentation of pyruvate to lactate is inhibited
CC       when bound to folliculin FLCN, perhaps partly by FLCN preventing
CC       binding of cofactor NADH (PubMed:34381247).
CC       {ECO:0000269|PubMed:34381247}.
CC   -!- PATHWAY: Fermentation; pyruvate fermentation to lactate; (S)-lactate
CC       from pyruvate: step 1/1. {ECO:0000305|PubMed:11276087}.
CC   -!- SUBUNIT: Homotetramer (PubMed:11276087). Interacts with PTEN upstream
CC       reading frame protein MP31 (PubMed:33406399). Interacts with folliculin
CC       FLCN; the interaction is direct and inhibits enzymatic activity
CC       (PubMed:34381247). {ECO:0000269|PubMed:11276087,
CC       ECO:0000269|PubMed:33406399, ECO:0000269|PubMed:34381247}.
CC   -!- INTERACTION:
CC       P00338; P11142: HSPA8; NbExp=4; IntAct=EBI-372327, EBI-351896;
CC       P00338; P00338: LDHA; NbExp=3; IntAct=EBI-372327, EBI-372327;
CC       P00338; P07195: LDHB; NbExp=3; IntAct=EBI-372327, EBI-358748;
CC       P00338-3; P07195: LDHB; NbExp=9; IntAct=EBI-10195200, EBI-358748;
CC       P00338-3; A0A286YFD7: MAPK10; NbExp=5; IntAct=EBI-10195200, EBI-17232183;
CC       P00338-3; Q499Y8: MAPK10; NbExp=3; IntAct=EBI-10195200, EBI-10241715;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P00338-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P00338-2; Sequence=VSP_014261, VSP_042787;
CC       Name=3;
CC         IsoId=P00338-3; Sequence=VSP_042206;
CC       Name=4;
CC         IsoId=P00338-4; Sequence=VSP_042786;
CC       Name=5;
CC         IsoId=P00338-5; Sequence=VSP_042788, VSP_042789;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in anaerobic tissues such
CC       as skeletal muscle and liver. {ECO:0000305|PubMed:11276087}.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798}.
CC   -!- DISEASE: Glycogen storage disease 11 (GSD11) [MIM:612933]: A metabolic
CC       disorder that results in exertional myoglobinuria, pain, cramps and
CC       easy fatigue. {ECO:0000269|PubMed:2334430}. Note=The disease is caused
CC       by variants affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the LDH/MDH superfamily. LDH family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Lactate dehydrogenase entry;
CC       URL="https://en.wikipedia.org/wiki/Lactate_dehydrogenase";
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Another dark horse - Issue
CC       109 of September 2009;
CC       URL="https://web.expasy.org/spotlight/back_issues/109";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X02152; CAA26088.1; -; mRNA.
DR   EMBL; X03077; CAA26879.1; -; Genomic_DNA.
DR   EMBL; X03078; CAA26879.1; JOINED; Genomic_DNA.
DR   EMBL; X03079; CAA26879.1; JOINED; Genomic_DNA.
DR   EMBL; X03080; CAA26879.1; JOINED; Genomic_DNA.
DR   EMBL; X03081; CAA26879.1; JOINED; Genomic_DNA.
DR   EMBL; X03082; CAA26879.1; JOINED; Genomic_DNA.
DR   EMBL; X03083; CAA26879.1; JOINED; Genomic_DNA.
DR   EMBL; AY423727; AAS00490.1; -; mRNA.
DR   EMBL; AK130587; BAC85389.1; -; mRNA.
DR   EMBL; AK296667; BAG59264.1; -; mRNA.
DR   EMBL; AK298834; BAH12879.1; -; mRNA.
DR   EMBL; CR456775; CAG33056.1; -; mRNA.
DR   EMBL; CR541714; CAG46515.1; -; mRNA.
DR   EMBL; AK223078; BAD96798.1; -; mRNA.
DR   EMBL; AC084117; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471064; EAW68395.1; -; Genomic_DNA.
DR   EMBL; CH471064; EAW68396.1; -; Genomic_DNA.
DR   EMBL; BC067223; AAH67223.1; -; mRNA.
DR   EMBL; S66853; AAB20418.1; -; Genomic_DNA.
DR   CCDS; CCDS44549.1; -. [P00338-4]
DR   CCDS; CCDS53609.1; -. [P00338-3]
DR   CCDS; CCDS53610.1; -. [P00338-2]
DR   CCDS; CCDS53611.1; -. [P00338-5]
DR   CCDS; CCDS7839.1; -. [P00338-1]
DR   PIR; A00347; DEHULM.
DR   RefSeq; NP_001128711.1; NM_001135239.1. [P00338-4]
DR   RefSeq; NP_001158886.1; NM_001165414.1. [P00338-3]
DR   RefSeq; NP_001158887.1; NM_001165415.1. [P00338-2]
DR   RefSeq; NP_001158888.1; NM_001165416.1. [P00338-5]
DR   RefSeq; NP_005557.1; NM_005566.3. [P00338-1]
DR   PDB; 1I10; X-ray; 2.30 A; A/B/C/D/E/F/G/H=2-332.
DR   PDB; 4AJP; X-ray; 2.38 A; A/B/C/D=2-332.
DR   PDB; 4JNK; X-ray; 1.90 A; A/B/C/D=2-332.
DR   PDB; 4L4R; X-ray; 2.10 A; A/H=2-332.
DR   PDB; 4L4S; X-ray; 2.90 A; A/H=2-332.
DR   PDB; 4M49; X-ray; 2.05 A; A/B/C/D=2-332.
DR   PDB; 4OJN; X-ray; 2.40 A; A/B/C/D/E/F/G/H=2-332.
DR   PDB; 4OKN; X-ray; 2.10 A; A/B/C/D/E/F/G/H=2-332.
DR   PDB; 4QO7; X-ray; 2.14 A; A/B/C/D=2-332.
DR   PDB; 4QO8; X-ray; 2.00 A; A/B/C/D=2-332.
DR   PDB; 4QSM; X-ray; 3.00 A; A/B/C/D/E/F/G/H=2-332.
DR   PDB; 4QT0; X-ray; 3.20 A; A/B/C/D/E/F/G/H=2-332.
DR   PDB; 4R68; X-ray; 2.11 A; A/B/C/D=2-332.
DR   PDB; 4R69; X-ray; 3.19 A; A/B/C/D=2-332.
DR   PDB; 4RLS; X-ray; 1.91 A; A/B/C/D=2-332.
DR   PDB; 4ZVV; X-ray; 2.20 A; A/B/C/D=1-332.
DR   PDB; 5IXS; X-ray; 2.05 A; A/B/C/D=2-332.
DR   PDB; 5IXY; X-ray; 3.00 A; A/B/C/D=2-332.
DR   PDB; 5W8H; X-ray; 1.80 A; A/B/C/D=1-332.
DR   PDB; 5W8I; X-ray; 1.95 A; A/B/C/D=1-332.
DR   PDB; 5W8J; X-ray; 1.55 A; A/B/C/D=1-332.
DR   PDB; 5W8K; X-ray; 1.60 A; A/B/C/D=1-332.
DR   PDB; 5W8L; X-ray; 1.95 A; A/B/C/D=1-332.
DR   PDB; 5ZJD; X-ray; 2.39 A; A/B/C/D/E/F/G/H=2-332.
DR   PDB; 5ZJE; X-ray; 2.93 A; A/B/C/D/E/F/G/H/I/J/K/L=2-332.
DR   PDB; 5ZJF; X-ray; 2.60 A; A/B/C/D/E/F/G/H/I/J/K/L=2-332.
DR   PDB; 6BAD; X-ray; 2.10 A; A/B/C/D=2-332.
DR   PDB; 6BAG; X-ray; 2.40 A; A/B/C/D=2-332.
DR   PDB; 6BAX; X-ray; 2.05 A; A/B/C/D=2-332.
DR   PDB; 6BAZ; X-ray; 2.70 A; A/B/C/D=2-332.
DR   PDB; 6BB0; X-ray; 1.95 A; A/B/C/D=2-332.
DR   PDB; 6BB1; X-ray; 2.30 A; A/B/C/D/E/F/G/H=2-332.
DR   PDB; 6BB2; X-ray; 2.47 A; A/B/C/D/E/F/G/H=2-332.
DR   PDB; 6BB3; X-ray; 2.40 A; A/B/C/D=2-332.
DR   PDB; 6MV8; X-ray; 1.95 A; A/B/C/D=1-332.
DR   PDB; 6MVA; X-ray; 2.02 A; A/B/C/D=1-332.
DR   PDB; 6Q0D; X-ray; 2.05 A; A/B/C/D/E/F=1-332.
DR   PDB; 6Q13; X-ray; 2.00 A; A/B/C/D=1-332.
DR   PDB; 6SBU; X-ray; 2.91 A; A/B/C/D/E/F/G/H=2-332.
DR   PDB; 6SBV; X-ray; 2.60 A; A/B/C/D/E/F/G/H=2-332.
DR   PDB; 6ZZR; X-ray; 2.65 A; AAA/BBB/CCC/DDD/EEE/FFF/GGG/HHH=2-332.
DR   PDB; 7M2N; X-ray; 2.50 A; A/B/C/D=1-332.
DR   PDBsum; 1I10; -.
DR   PDBsum; 4AJP; -.
DR   PDBsum; 4JNK; -.
DR   PDBsum; 4L4R; -.
DR   PDBsum; 4L4S; -.
DR   PDBsum; 4M49; -.
DR   PDBsum; 4OJN; -.
DR   PDBsum; 4OKN; -.
DR   PDBsum; 4QO7; -.
DR   PDBsum; 4QO8; -.
DR   PDBsum; 4QSM; -.
DR   PDBsum; 4QT0; -.
DR   PDBsum; 4R68; -.
DR   PDBsum; 4R69; -.
DR   PDBsum; 4RLS; -.
DR   PDBsum; 4ZVV; -.
DR   PDBsum; 5IXS; -.
DR   PDBsum; 5IXY; -.
DR   PDBsum; 5W8H; -.
DR   PDBsum; 5W8I; -.
DR   PDBsum; 5W8J; -.
DR   PDBsum; 5W8K; -.
DR   PDBsum; 5W8L; -.
DR   PDBsum; 5ZJD; -.
DR   PDBsum; 5ZJE; -.
DR   PDBsum; 5ZJF; -.
DR   PDBsum; 6BAD; -.
DR   PDBsum; 6BAG; -.
DR   PDBsum; 6BAX; -.
DR   PDBsum; 6BAZ; -.
DR   PDBsum; 6BB0; -.
DR   PDBsum; 6BB1; -.
DR   PDBsum; 6BB2; -.
DR   PDBsum; 6BB3; -.
DR   PDBsum; 6MV8; -.
DR   PDBsum; 6MVA; -.
DR   PDBsum; 6Q0D; -.
DR   PDBsum; 6Q13; -.
DR   PDBsum; 6SBU; -.
DR   PDBsum; 6SBV; -.
DR   PDBsum; 6ZZR; -.
DR   PDBsum; 7M2N; -.
DR   AlphaFoldDB; P00338; -.
DR   SMR; P00338; -.
DR   BioGRID; 110131; 312.
DR   ComplexPortal; CPX-6573; L-lactate dehydrogenase A complex.
DR   ComplexPortal; CPX-6592; L-lactate dehydrogenase complex, A3B1 variant.
DR   ComplexPortal; CPX-6594; L-lactate dehydrogenase complex, A2B2 variant.
DR   ComplexPortal; CPX-6598; L-lactate dehydrogenase complex, A1B3 variant.
DR   IntAct; P00338; 77.
DR   MINT; P00338; -.
DR   STRING; 9606.ENSP00000445175; -.
DR   BindingDB; P00338; -.
DR   ChEMBL; CHEMBL4835; -.
DR   DrugBank; DB11638; Artenimol.
DR   DrugBank; DB09130; Copper.
DR   DrugBank; DB02483; Etheno-NAD.
DR   DrugBank; DB00157; NADH.
DR   DrugBank; DB02701; Nicotinamide.
DR   DrugBank; DB03940; Oxamic Acid.
DR   DrugBank; DB09118; Stiripentol.
DR   DrugCentral; P00338; -.
DR   GlyCosmos; P00338; 1 site, 2 glycans.
DR   GlyGen; P00338; 2 sites, 2 O-linked glycans (2 sites).
DR   iPTMnet; P00338; -.
DR   MetOSite; P00338; -.
DR   PhosphoSitePlus; P00338; -.
DR   SwissPalm; P00338; -.
DR   BioMuta; LDHA; -.
DR   DMDM; 126047; -.
DR   DOSAC-COBS-2DPAGE; P00338; -.
DR   OGP; P00338; -.
DR   REPRODUCTION-2DPAGE; IPI00217966; -.
DR   CPTAC; CPTAC-2749; -.
DR   CPTAC; CPTAC-2750; -.
DR   CPTAC; CPTAC-91; -.
DR   EPD; P00338; -.
DR   jPOST; P00338; -.
DR   MassIVE; P00338; -.
DR   MaxQB; P00338; -.
DR   PaxDb; P00338; -.
DR   PeptideAtlas; P00338; -.
DR   ProteomicsDB; 51230; -. [P00338-1]
DR   ProteomicsDB; 51231; -. [P00338-2]
DR   ProteomicsDB; 51232; -. [P00338-3]
DR   ProteomicsDB; 51233; -. [P00338-4]
DR   ProteomicsDB; 51234; -. [P00338-5]
DR   TopDownProteomics; P00338-1; -. [P00338-1]
DR   TopDownProteomics; P00338-4; -. [P00338-4]
DR   TopDownProteomics; P00338-5; -. [P00338-5]
DR   Antibodypedia; 4200; 981 antibodies from 40 providers.
DR   DNASU; 3939; -.
DR   Ensembl; ENST00000227157.8; ENSP00000227157.4; ENSG00000134333.15. [P00338-5]
DR   Ensembl; ENST00000379412.9; ENSP00000368722.6; ENSG00000134333.15. [P00338-1]
DR   Ensembl; ENST00000396222.6; ENSP00000379524.2; ENSG00000134333.15. [P00338-2]
DR   Ensembl; ENST00000422447.8; ENSP00000395337.3; ENSG00000134333.15. [P00338-1]
DR   Ensembl; ENST00000430553.6; ENSP00000406172.2; ENSG00000134333.15. [P00338-4]
DR   Ensembl; ENST00000542179.1; ENSP00000445331.1; ENSG00000134333.15. [P00338-1]
DR   Ensembl; ENST00000671981.1; ENSP00000499898.1; ENSG00000288299.1. [P00338-1]
DR   Ensembl; ENST00000672078.1; ENSP00000500354.1; ENSG00000288299.1. [P00338-5]
DR   Ensembl; ENST00000672405.1; ENSP00000500953.1; ENSG00000288299.1. [P00338-1]
DR   Ensembl; ENST00000672996.1; ENSP00000500284.1; ENSG00000288299.1. [P00338-4]
DR   Ensembl; ENST00000673007.1; ENSP00000500603.1; ENSG00000288299.1. [P00338-3]
DR   Ensembl; ENST00000673083.1; ENSP00000500168.1; ENSG00000288299.1. [P00338-2]
DR   Ensembl; ENST00000673204.1; ENSP00000499977.1; ENSG00000288299.1. [P00338-1]
DR   GeneID; 3939; -.
DR   KEGG; hsa:3939; -.
DR   MANE-Select; ENST00000422447.8; ENSP00000395337.3; NM_005566.4; NP_005557.1.
DR   UCSC; uc001mol.4; human. [P00338-1]
DR   AGR; HGNC:6535; -.
DR   CTD; 3939; -.
DR   DisGeNET; 3939; -.
DR   GeneCards; LDHA; -.
DR   HGNC; HGNC:6535; LDHA.
DR   HPA; ENSG00000134333; Low tissue specificity.
DR   MalaCards; LDHA; -.
DR   MIM; 150000; gene.
DR   MIM; 612933; phenotype.
DR   neXtProt; NX_P00338; -.
DR   OpenTargets; ENSG00000134333; -.
DR   Orphanet; 284426; Glycogen storage disease due to lactate dehydrogenase M-subunit deficiency.
DR   PharmGKB; PA30319; -.
DR   VEuPathDB; HostDB:ENSG00000134333; -.
DR   eggNOG; KOG1495; Eukaryota.
DR   GeneTree; ENSGT00940000153201; -.
DR   HOGENOM; CLU_045401_0_2_1; -.
DR   InParanoid; P00338; -.
DR   OMA; CYIIVLT; -.
DR   OrthoDB; 5344346at2759; -.
DR   PhylomeDB; P00338; -.
DR   TreeFam; TF314963; -.
DR   BRENDA; 1.1.1.27; 2681.
DR   PathwayCommons; P00338; -.
DR   Reactome; R-HSA-70268; Pyruvate metabolism.
DR   SABIO-RK; P00338; -.
DR   SignaLink; P00338; -.
DR   SIGNOR; P00338; -.
DR   UniPathway; UPA00554; UER00611.
DR   BioGRID-ORCS; 3939; 203 hits in 1153 CRISPR screens.
DR   ChiTaRS; LDHA; human.
DR   EvolutionaryTrace; P00338; -.
DR   GeneWiki; LDHA; -.
DR   GenomeRNAi; 3939; -.
DR   Pharos; P00338; Tchem.
DR   PRO; PR:P00338; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; P00338; protein.
DR   Bgee; ENSG00000134333; Expressed in ventricular zone and 115 other tissues.
DR   ExpressionAtlas; P00338; baseline and differential.
DR   Genevisible; P00338; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:1990204; C:oxidoreductase complex; IPI:ComplexPortal.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0004459; F:L-lactate dehydrogenase activity; IMP:UniProtKB.
DR   GO; GO:0006096; P:glycolytic process; NAS:UniProtKB.
DR   GO; GO:0006089; P:lactate metabolic process; IDA:ComplexPortal.
DR   GO; GO:0006090; P:pyruvate metabolic process; IDA:ComplexPortal.
DR   GO; GO:0021762; P:substantia nigra development; HEP:UniProtKB.
DR   CDD; cd05293; LDH_1; 1.
DR   Gene3D; 3.90.110.10; Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal; 1.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1.
DR   HAMAP; MF_00488; Lactate_dehydrog; 1.
DR   InterPro; IPR001557; L-lactate/malate_DH.
DR   InterPro; IPR011304; L-lactate_DH.
DR   InterPro; IPR018177; L-lactate_DH_AS.
DR   InterPro; IPR022383; Lactate/malate_DH_C.
DR   InterPro; IPR001236; Lactate/malate_DH_N.
DR   InterPro; IPR015955; Lactate_DH/Glyco_Ohase_4_C.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   PANTHER; PTHR43128; L-2-HYDROXYCARBOXYLATE DEHYDROGENASE (NAD(P)(+)); 1.
DR   PANTHER; PTHR43128:SF10; L-LACTATE DEHYDROGENASE A CHAIN; 1.
DR   Pfam; PF02866; Ldh_1_C; 1.
DR   Pfam; PF00056; Ldh_1_N; 1.
DR   PIRSF; PIRSF000102; Lac_mal_DH; 1.
DR   PRINTS; PR00086; LLDHDRGNASE.
DR   SUPFAM; SSF56327; LDH C-terminal domain-like; 1.
DR   SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1.
DR   PROSITE; PS00064; L_LDH; 1.
DR   TIGRFAMs; TIGR01771; L-LDH-NAD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cytoplasm;
KW   Direct protein sequencing; Disease variant; Glycogen storage disease;
KW   Isopeptide bond; NAD; Oxidoreductase; Phosphoprotein; Reference proteome;
KW   Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.10, ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895"
FT   CHAIN           2..332
FT                   /note="L-lactate dehydrogenase A chain"
FT                   /id="PRO_0000168411"
FT   ACT_SITE        193
FT                   /note="Proton acceptor"
FT   BINDING         29..57
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:11276087"
FT   BINDING         99
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:11276087"
FT   BINDING         106
FT                   /ligand="substrate"
FT   BINDING         138
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:11276087"
FT   BINDING         138
FT                   /ligand="substrate"
FT   BINDING         169
FT                   /ligand="substrate"
FT   BINDING         248
FT                   /ligand="substrate"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|Ref.10, ECO:0007744|PubMed:19413330,
FT                   ECO:0007744|PubMed:22223895"
FT   MOD_RES         5
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         5
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06151"
FT   MOD_RES         10
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         14
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         18
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         57
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         81
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         118
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         118
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06151"
FT   MOD_RES         126
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         224
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06151"
FT   MOD_RES         232
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06151"
FT   MOD_RES         239
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P06151"
FT   MOD_RES         243
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P06151"
FT   MOD_RES         309
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P04642"
FT   MOD_RES         310
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         318
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0007744|PubMed:19608861"
FT   MOD_RES         318
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P06151"
FT   MOD_RES         322
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P04642"
FT   CROSSLNK        57
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         1
FT                   /note="M -> MGEPSGGYTYTQTSIFLFHAKIPFGSKSNM (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042206"
FT   VAR_SEQ         82..139
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042786"
FT   VAR_SEQ         230..274
FT                   /note="VHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVS -> CRY
FT                   TLGDPKGAAILKSSDVISFHCLGYNRILGGGCACCPFYLICD (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_014261"
FT   VAR_SEQ         237..241
FT                   /note="SAYEV -> RVFTE (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_042788"
FT   VAR_SEQ         242..332
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_042789"
FT   VAR_SEQ         275..332
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_042787"
FT   VARIANT         222
FT                   /note="K -> E (in dbSNP:rs748436361)"
FT                   /evidence="ECO:0000269|PubMed:7908613, ECO:0000269|Ref.6"
FT                   /id="VAR_004180"
FT   VARIANT         315
FT                   /note="R -> C (in dbSNP:rs200093825)"
FT                   /evidence="ECO:0000269|PubMed:1445373"
FT                   /id="VAR_004181"
FT   MUTAGEN         56
FT                   /note="D->A: Abolishes interaction with MP31."
FT                   /evidence="ECO:0000269|PubMed:33406399"
FT   MUTAGEN         99
FT                   /note="R->A: Abolishes interaction with MP31."
FT                   /evidence="ECO:0000269|PubMed:33406399"
FT   MUTAGEN         106
FT                   /note="R->A,K,Q: Increases binding to FLCN."
FT                   /evidence="ECO:0000269|PubMed:34381247"
FT   HELIX           4..8
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   STRAND          9..11
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   STRAND          20..26
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   HELIX           30..41
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   STRAND          46..51
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   HELIX           55..67
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   HELIX           68..71
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   STRAND          76..79
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   HELIX           83..86
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   STRAND          90..94
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   HELIX           106..127
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   STRAND          132..135
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   STRAND          137..139
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   HELIX           140..151
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   HELIX           155..157
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   STRAND          158..160
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   HELIX           164..178
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   HELIX           182..184
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   STRAND          189..194
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   STRAND          197..199
FT                   /evidence="ECO:0007829|PDB:5W8I"
FT   HELIX           201..203
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   HELIX           211..214
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   TURN            216..219
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   STRAND          220..222
FT                   /evidence="ECO:0007829|PDB:6Q0D"
FT   HELIX           228..245
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   HELIX           250..264
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   STRAND          269..276
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   STRAND          278..280
FT                   /evidence="ECO:0007829|PDB:5ZJE"
FT   STRAND          288..296
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   STRAND          299..304
FT                   /evidence="ECO:0007829|PDB:5W8J"
FT   HELIX           310..327
FT                   /evidence="ECO:0007829|PDB:5W8J"
SQ   SEQUENCE   332 AA;  36689 MW;  401E8604CEB7F908 CRC64;
     MATLKDQLIY NLLKEEQTPQ NKITVVGVGA VGMACAISIL MKDLADELAL VDVIEDKLKG
     EMMDLQHGSL FLRTPKIVSG KDYNVTANSK LVIITAGARQ QEGESRLNLV QRNVNIFKFI
     IPNVVKYSPN CKLLIVSNPV DILTYVAWKI SGFPKNRVIG SGCNLDSARF RYLMGERLGV
     HPLSCHGWVL GEHGDSSVPV WSGMNVAGVS LKTLHPDLGT DKDKEQWKEV HKQVVESAYE
     VIKLKGYTSW AIGLSVADLA ESIMKNLRRV HPVSTMIKGL YGIKDDVFLS VPCILGQNGI
     SDLVKVTLTS EEEARLKKSA DTLWGIQKEL QF
//
